|Articles|July 7, 2004
Miravant PDT laser receives expedited review status
The FDA accepted for filing and granted Expedited Review status to Miravant Medical Technologies' premarket application (PMA) for the IRIS Medical OcuLight 664 ophthalmic PDT laser.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5
























